Celanese cuts 2024 profit forecast on sluggish demand, production snags
Aug 1 (Reuters) -Specialty chemicals company Celanese CE.N lowered its 2024 earnings forecast on Thursday, hurt by weak demand in several key sectors and production obstacles, sending its shares down 5.4% after the bell.
China's manufacturing activity contracted in May and June, with economic data in the last month of the quarter showing indexes of raw material stocks in contractionary territory. Manufacturing activity across the eurozone also declined in June.
Celanese had declared force majeure for its acetic acid and vinyl acetate monomer products sold in the Western Hemisphere due to raw materials shortages and operational issues in June.
The company said that total losses attributable to unplanned supplier disruptions at its low-cost production facility Clear Lake were the highest in over 15 years and the plant experienced 66 days of feedstock curtailments.
It trimmed its 2024 earnings forecast to the range of $10.25 to $10.75 per share, compared with earlier forecast of $11 to $12 per share. The updated forecast fell short of Wall Street estimates of $11.11 per share, according to LSEG data.
"We expect third quarter market dynamics to be similar to the first half of the year and expect continued challenges to the macro-environment for the balance of 2024," the company said in its prepared earnings remarks.
Celanese also reported second-quarter adjusted profit of $2.38 per share, missing estimates of $2.71 per share.
Net sales during the second quarter at its Acetyl Chain segment fell 5% sequentially, hurt by decline in both prices and volumes.
"We are seeing stability but not recovery to normalized levels," CEO Lori Ryerkerk said.
Reporting by Sourasis Bose in Bengaluru; editing by Alan Barona
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
